John F. Rothrock MD
Professor and Vice Chair, Department of Neurology, George Washington University School of Medicine, Washington, DCDr. Rothrock graduated from the University of Virginia School of Medicine and subsequently completed a neurology residency at the University of Arizona. In 1983 he joined the neurosciences faculty of the University of California, San Diego (UCSD). Over the ensuing years he established and directed the UCSD Stroke Center and, subsequently, the UCSD Headache Center.
In 1994 he left UCSD to serve as chair of neurology and associate dean for clinical research at the University of South Alabama and subsequently as vice chair of neurology at the University of Alabama/Birmingham. In 2015 he began working in in his present position as a professor and vice chair of neurology at the George Washington University School of Medicine.
Along with conducting epidemiologic research intended to better characterize various aspects of cerebrovascular disease and migraine, Dr. Rothrock has assisted in the development of such therapies as intravenous t-PA and thrombectomy for acute stroke, warfarin for stroke prevention in individuals with atrial fibrillation, clopidogrel for stroke prevention, self-injectable sumatriptan for acute migraine, and divalproex sodium, topiramate, onabotulinumtoxinA and various of the anti-CGRP monoclonal antibodies for migraine prophylaxis.
From 2001 to 2013 Dr. Rothrock served as editor-in-chief of Headache, the journal of the American Headache Society.
Dr. Rothrock is board-certified in neurology and subspeciality board-certified in vascular neurology (stroke) and headache medicine.